| MELIX | RNWBX | MELIX / RNWBX | |
| Total Expense Ratio | 0.99 | 1.67 | 59% |
| Annual Report Gross Expense Ratio | 1.16 | 1.67 | 69% |
| Fund Existence | 14 years | 23 years | - |
| Gain YTD | 12.069 | 27.152 | 44% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 129M | 76.6B | 0% |
| Annual Yield % from dividends | 0.00 | 0.12 | - |
| Returns for 1 year | 5.10 | 20.32 | 25% |
| Returns for 3 years | 26.03 | 47.10 | 55% |
| Returns for 5 years | -7.70 | 21.37 | -36% |
| Returns for 10 years | 76.41 | 93.86 | 81% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EEMDX | 10.22 | 0.02 | +0.20% |
| MFS Emerging Markets Equity Research R1 | |||
| SVOAX | 15.06 | 0.02 | +0.13% |
| SEI US Managed Volatility F (SIMT) | |||
| LMCKX | 8.83 | 0.01 | +0.11% |
| Miller Income FI | |||
| FCDTX | 38.04 | N/A | N/A |
| Fidelity Advisor Stock Selector Sm Cp M | |||
| ETCHX | 41.10 | -0.08 | -0.19% |
| Eventide Healthcare & Life Sciences C | |||